97 related articles for article (PubMed ID: 2013245)
1. Therapy of serious skin and soft tissue infections with ofloxacin administered by intravenous and oral route.
Lentino JR; Augustinsky JB; Weber TM; Pachucki CT
Chemotherapy; 1991; 37(1):70-6. PubMed ID: 2013245
[TBL] [Abstract][Full Text] [Related]
2. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.
Gentry LO; Rodriguez-Gomez G; Zeluff BJ; Khoshdel A; Price M
Am J Med; 1989 Dec; 87(6C):57S-60S. PubMed ID: 2690621
[TBL] [Abstract][Full Text] [Related]
3. Ofloxacin treatment of difficult infections of the skin and skin structure.
Gentry LO; Rodriguez-Gomez G
Cutis; 1993 Jan; 51(1):55-8. PubMed ID: 8419113
[TBL] [Abstract][Full Text] [Related]
4. Ofloxacin versus cephalexin in the treatment of skin, skin structure, and soft-tissue infections in adults.
Powers RD; Schwartz R; Snow RM; Yarbrough DR
Clin Ther; 1991; 13(6):727-36. PubMed ID: 1790547
[TBL] [Abstract][Full Text] [Related]
5. Oral ofloxacin for infections caused by bacteria resistant to oral antimicrobial agents.
Eron LJ; Gentry LO
Diagn Microbiol Infect Dis; 1992 Jul; 15(5):435-9. PubMed ID: 1643820
[TBL] [Abstract][Full Text] [Related]
6. Fleroxacin 400 mg once daily versus ofloxacin 400 mg twice daily in skin and soft tissue infections.
Drehobl M; Koenig L; Barker M; St Clair P; Maladorno D
Chemotherapy; 1997; 43(5):378-84. PubMed ID: 9309373
[TBL] [Abstract][Full Text] [Related]
7. Ofloxacin use in a geriatric population.
Nicolle LE; Degelau J; Alessi P; Cullison J; Meyers B
Chemotherapy; 1991; 37 Suppl 1():49-54. PubMed ID: 2049965
[TBL] [Abstract][Full Text] [Related]
8. Ofloxacin versus cephalexin for treating skin and soft tissue infections.
Lipsky BA; Yarbrough DR; Walker FB; Powers RD; Morman MR
Int J Dermatol; 1992 Jun; 31(6):443-5. PubMed ID: 1512105
[TBL] [Abstract][Full Text] [Related]
9. Soft tissue infections in the emergency department: the case for the use of 'simple' antibiotics.
Powers RD
South Med J; 1991 Nov; 84(11):1313-5. PubMed ID: 1948213
[TBL] [Abstract][Full Text] [Related]
10. [Clinical trials of ofloxacin in sequential use (intravenous and oral) in patients with serious hospital infection].
Iakovlev SV; Dvoretskiĭ LI; Shakhova TV; Kudinkina IP; Vorob'ev PA; Vlasenko NA; Prokhorenko TS; Eremina LV
Antibiot Khimioter; 1996; 41(9):53-6. PubMed ID: 9005788
[TBL] [Abstract][Full Text] [Related]
11. Teicoplanin in the treatment of skin and soft tissue infections.
Turpin PJ; Taylor GP; Logan MN; Wood MJ
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():117-22. PubMed ID: 2965123
[TBL] [Abstract][Full Text] [Related]
12. Intravenous fleroxacin versus ceftazidime for lower respiratory tract and skin and soft-tissue infections.
Huston MJ; Lentino JR
Clin Ther; 1992; 14(4):595-602. PubMed ID: 1525793
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin for soft tissue infections.
Wood MJ; Logan MN
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():159-64. PubMed ID: 3804904
[TBL] [Abstract][Full Text] [Related]
14. Therapy of skin, soft tissue, and bone infections with cefoxitin sodium.
Perkins RL; Slama TG; Fass RJ; Prior RB; Plouffe JF; Warner JF; File TM
Rev Infect Dis; 1979; 1(1):165-9. PubMed ID: 318218
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with parenteral and oral ofloxacin in severe infections.
Kanellakopoulou K; Giamarellou H
Scand J Infect Dis Suppl; 1990; 68():64-9. PubMed ID: 2218425
[TBL] [Abstract][Full Text] [Related]
16. Intravenous ofloxacin in severe infections.
Graninger W; Presterl E; Walzl B; Lackner R; Haslinger B; Hackl W
J Antimicrob Chemother; 1990 Nov; 26 Suppl D():123-35. PubMed ID: 2286587
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
Sharpe JN; Shively EH; Polk HC
Am J Surg; 2005 Apr; 189(4):425-8. PubMed ID: 15820454
[TBL] [Abstract][Full Text] [Related]
18. Oral ofloxacin therapy for invasive external otitis.
Zikk D; Rapoport Y; Redianu C; Shalit I; Himmelfarb MZ
Ann Otol Rhinol Laryngol; 1991 Aug; 100(8):632-7. PubMed ID: 1908200
[TBL] [Abstract][Full Text] [Related]
19. High-pressure liquid chromatography and microbiological assay of serum ofloxacin levels in adults receiving intravenous and oral therapy for skin infections.
Auten GM; Preheim LC; Sookpranee M; Bittner MJ; Sookpranee T; Vibhagool A
Antimicrob Agents Chemother; 1991 Dec; 35(12):2558-61. PubMed ID: 1810189
[TBL] [Abstract][Full Text] [Related]
20. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.
Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
Am J Med; 1990 Jan; 88(1):36-42. PubMed ID: 2153006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
